This study also assessed the correlation between hepcidin levels and a commonly used breast cancer biomarker, the cancer antigen 15‐3 (CA15‐3), and one of the potential regulators of hepcidin in cancers, the C‐reactive protein (CRP). Here, HAMP is linked to breast carcinoma.